0001604689-17-000004.txt : 20170510 0001604689-17-000004.hdr.sgml : 20170510 20170510164419 ACCESSION NUMBER: 0001604689-17-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170503 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001457612 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 510596811 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-876-8191 MAIL ADDRESS: STREET 1: 100 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC DATE OF NAME CHANGE: 20090304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Poole Jonathan CENTRAL INDEX KEY: 0001604689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36289 FILM NUMBER: 17831102 MAIL ADDRESS: STREET 1: C/O GENOCEA BIOSCIENCES, INC. STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 wf-form4_149444904447921.xml FORM 4 X0306 4 2017-05-03 0 0001457612 GENOCEA BIOSCIENCES, INC. GNCA 0001604689 Poole Jonathan C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 Chief Financial Officer Common Stock 2017-05-03 4 A 0 7937 0 A 25150 D Common Stock 2017-05-03 4 A 0 23810 0 A 48960 D Common Stock 2017-05-08 4 S 0 6213 6.51 D 42747 D Common Stock 2017-05-10 4 F 0 3500 6.13 D 39247 D The restricted stock units ("RSUs") were granted in accordance with Genocea Biosciences, Inc.'s (the "Company") 2014 Equity Incentive Plan (the "Plan") and vested immediately upon grant. The RSUs were granted in accordance with the Plan and will vest in full 18 months from the grant date, subject to Mr. Poole's continued employment with the Company. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.50 to $6.54, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Shares sold to cover taxes on RSUs that vested on May 3, 2017. /s/ Jonathan Poole 2017-05-10